Universe's 15-minute chart triggers KDJ Golden Cross, bullish Marubozu pattern emerges.
ByAinvest
Monday, Oct 13, 2025 10:17 am ET1min read
GLTO--
Galecto Inc. experienced the largest increase in momentum, rising from a score of 9.3 to 96.64. The stock is trading far above its 50-day moving average, currently at $15.70 compared to the 50-day average of $3.77 [1].
Xenetic Biosciences Inc. saw a momentum gain of 75.56 points, rising from 21.97 to 97.53. The stock is also trading above its 50-day moving average, currently at $9.70 compared to the 50-day average of $3.23 [1].
Universe Pharmaceuticals Inc. had the third largest increase in momentum score, rising from 12.95 to 82.24. The stock is trading above its 50-day moving average, currently at $6.40 compared to the 50-day average of $4.02 [1].
Alaunos Therapeutics, Inc. rounds out the list, gaining 68.77 points since last week to rise from 15.88 to 84.65. The stock is trading above its 50-day moving average, currently at $3.95 compared to the 50-day average of $2.43 [1].
Price action on Thursday saw Galecto stock trading 28.27% higher at $13.85, Xenetic shares trading 9.27% lower at $9.40, Universe shares trading 33.30% lower at $6.31, and Alaunos shares trading 6.49% higher at $3.96 [1].
In addition to these momentum shifts, Universe Pharmaceuticals has recently exhibited a KDJ Golden Cross on its 15-minute chart, accompanied by a Bullish Marubozu at 10:15 on October 13, 2025. This suggests that the stock price is trending upwards and has the potential to continue increasing as buyers maintain control of the market [1].
Investors should monitor these stocks closely for further developments. As always, it is important to conduct thorough research and consider seeking professional financial advice before making investment decisions.
TCRT--
UPC--
XBIO--
The 15-minute chart for Universe has recently exhibited a KDJ Golden Cross, accompanied by a Bullish Marubozu at 10:15 on October 13, 2025. This shift in momentum suggests that the stock price is trending upwards and has the potential to continue increasing. As buyers maintain control of the market, bullish momentum is likely to persist.
Healthcare and biotech stocks have been lagging behind broader markets this year, but a growing number of names are showing signs of picking up momentum. According to Benzinga's Edge Stock Rankings system, four biotech stocks have posted significant increases in bullish momentum over the past week. These stocks, Galecto Inc. (GLTO), Xenetic Biosciences Inc. (XBIO), Universe Pharmaceuticals Inc. (UPC), and Alaunos Therapeutics, Inc. (TCRT), are leading the charge with impressive gains.Galecto Inc. experienced the largest increase in momentum, rising from a score of 9.3 to 96.64. The stock is trading far above its 50-day moving average, currently at $15.70 compared to the 50-day average of $3.77 [1].
Xenetic Biosciences Inc. saw a momentum gain of 75.56 points, rising from 21.97 to 97.53. The stock is also trading above its 50-day moving average, currently at $9.70 compared to the 50-day average of $3.23 [1].
Universe Pharmaceuticals Inc. had the third largest increase in momentum score, rising from 12.95 to 82.24. The stock is trading above its 50-day moving average, currently at $6.40 compared to the 50-day average of $4.02 [1].
Alaunos Therapeutics, Inc. rounds out the list, gaining 68.77 points since last week to rise from 15.88 to 84.65. The stock is trading above its 50-day moving average, currently at $3.95 compared to the 50-day average of $2.43 [1].
Price action on Thursday saw Galecto stock trading 28.27% higher at $13.85, Xenetic shares trading 9.27% lower at $9.40, Universe shares trading 33.30% lower at $6.31, and Alaunos shares trading 6.49% higher at $3.96 [1].
In addition to these momentum shifts, Universe Pharmaceuticals has recently exhibited a KDJ Golden Cross on its 15-minute chart, accompanied by a Bullish Marubozu at 10:15 on October 13, 2025. This suggests that the stock price is trending upwards and has the potential to continue increasing as buyers maintain control of the market [1].
Investors should monitor these stocks closely for further developments. As always, it is important to conduct thorough research and consider seeking professional financial advice before making investment decisions.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet